Drug Discovery Today logo Elsevier logo

Publisher: Elsevier

Related content
Volume 8, Number 2, 15 January 2003

< previous issue | all issues | next issue >

Squirreling away at Parkinson's
pp. 51-52(2)
Author: May, T.S.

Mistletoe compound enters clinical trials
pp. 52-53(2)
Author: Habeck, M.

Bad bugs: good for cancer therapy?
pp. 54-55(2)
Author: Burnham, C.M.

News in brief
pp. 55-58(4)
Authors: Brown, M.; Chan, P.; Viccars, C.; Wild, C.; Yeomans, H.

pp. 59-59(1)
Author: Chan, P.

Rontgen rays revealed
pp. 60-61(2)
Author: Rowe, R.C.

Polymers for drug delivery: the debate continues ?
pp. 62-62(1)
Authors: Storm, G.; Woodle, M.C.

Non-viral cancer gene therapy - what is best? ?
pp. 63-63(1)
Author: Ogris, M.

A new era in cancer therapeutics?
pp. 64-65(2)
Author: Westwell, A.D.

Reductionism in the Biomedical Sciences
pp. 66-66(1)
Author: Voit, E.O.

Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design
pp. 67-77(11)
Authors: Los, M.; Burek, C.J.; Stroh, C.; Benedyk, K.; Hug, H.; Mackiewicz, A.

Nuclear transport as a target for cell growth
pp. 78-85(8)
Authors: Kau, T.R.; Silver, P.A.

Nonleadlikeness and leadlikeness in biochemical screening
pp. 86-96(11)
Author: Rishton, G.M.

Monitor: molecules and profiles
pp. 97-97(1)
Author: Barlocco, D.

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page